Study of ABCB1 polymorphism frequency in breast cancer patients from Poland

Pharmacological Reports

Volumn 64, Issue 6, 2012, Pages 1560-1566

  Rubiś, Błazej ^a   Hołysz, Hanna ^a   Barczak, Wojciech ^a   Gryczka, Robert ^a   Łaciński, Mariusz ^a   Jagielski, Paweł ^b   Czernikiewicz, Anna ^a   Półrolniczak, Anna ^a   Wojewoda, Aneta ^a   Perz, Katarzyna ^a   Białek, Paweł ^a   Morze, Karolina ^a   Kanduła, Zuzanna ^a   Lisiak, Natalia ^a   Mrozikiewicz, Przemysław M ^a   Grodecka Gazdecka, Sylwia ^a   Rybczyńska, Maria ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

ABCB1; Breast cancer risk; Glycoprotein P; Multidrug resistance; Polymorphism

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; RESTRICTION ENDONUCLEASE; RESTRICTION ENDONUCLEASE SAU3AI; UNCLASSIFIED DRUG;

ABCB1 GENE; ADULT; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLAND; POLISH; POPULATION RESEARCH; PREDICTIVE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 84873732965     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70954-4     Document Type: Article

References (32)

1. Abbasi M, Lavasanifar A, Berthiaume LG, Weinfeld M, Uludag H: Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. Cancer, 2010, 116, 5544-5554.
2. Ashariati A: Polymorphism C3435T of the MDR-1 gene predict response to preoperative chemotherapy in locally advanced breast cancer with Her2/neu expression. Acta Med Indones, 2008, 40, 187-191.
3. Balcerczak E, Panczyk M, Piaskowski S, Pasz-Walczak G, Salagacka A, Mirowski M: ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis, 2010, 25, 1167-1176.
4. Cascorbi I, Haenisch S: Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Methods Mol Biol, 2010, 596, 95-121.
5. Chang H, Rha SY, Jeung HC, Im CK, Ahn JB, Kwon WS, Yoo NC et al.: Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Ann Oncol, 2009, 20, 272-277.
6. Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, Sarissky M et al.: MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J, 2009, 10, 62-69.
7. Drozdzik M, Mysliwiec K, Lewinska-Chelstowska M, Banach J, Drozdzik A, Grabarek J: P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth. J Clin Periodontol, 2004, 31, 758-763. (Pubitemid 39186430)
8. Fung KL, Gottesman MM: A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta, 2009, 1794, 860-871.
9. George J, Dharanipragada K, Krishnamachari S, Chandrasekaran A, Sam SS, Sunder E: A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer. Clin Breast Cancer, 2009, 9, 161-165.
10. Gonzalez TP, Mucenic T, Brenol JC, Xavier RM, Schiengold M, Chies JA: ABCB1 C1236T, G2677T/A and C3435T polymorphisms in systemic lupus erythematosus patients. Braz J Med Biol Res, 2008, 41, 769-772.
11. Hamidovic A, Hahn K, Kolesar J: Clinical significance of ABCB1 genotyping in oncology. J Oncol Pharm Pract, 2010, 16, 39-44.
12. Haros M, Bielecka M, Sanz Y: Phytase activity as a novel metabolic feature in Bifidobacterium . FEMS Microbiol Lett, 2005, 247, 231-239. (Pubitemid 40799197)
13. Henriquez-Hernandez LA, Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, Diaz-Chico BN, Mori De Santiago M, Fernandez Perez L: Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep, 2009, 22, 1425-1433.
14. Huang MY, Wang YH, Chen FM, Lee SC, Fang WY, Cheng TL, Hou MF et al.: Multiple genetic polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC highly correlated with early relapse of breast cancer patients in Taiwan. Ann Surg Oncol, 2008, 15, 872-880.
15. Hutson JR, Koren G, Matthews SG: Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. Placenta, 2010, 31, 351-357.
16. Ichihara S, Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Kojima T et al.: Association of a polymorphism of ABCB1 with obesity in Japanese individuals. Genomics, 2008, 91, 512-516.
17. Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H: Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol, 2003, 22, 1117-1121.
18. Kurzawski M, Pawlik A, Górnik W Droździk M: Frequency of common MDR1 gene variants in a Polish population. Pharmacol Rep, 2006, 58, 35-40.
19. Kwon WS, Rha SY, Jeung HC, Ahn JB, Jung JJ, Noh SH, Chung HC: G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern. Cancer Lett, 2009, 277, 155-163.
20. Leschziner G, Jorgensen AL, Andrew T, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ et al.: Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study. Lancet Neurol, 2006, 5, 668-676. (Pubitemid 44062410)
21. Lu PH, Wei MX, Yang J, Liu X, Tao GQ, Shen W, Chen MB: Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat, 2011, 125, 537-543.
22. Maeda K, Sugiyama Y: Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab Pharmacokinet, 2008, 23, 223-235.
23. Kimch-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gossesman MM: A silent polymorphism in the MDR1 gene changes substrate specificity . Science, 2007, 315, 525-528. (Pubitemid 46175758)
24. Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M et al.: ABCB1 and GST polymorphisms associated with TP53 status in breast cancer. Pharmacogenet Genomics, 2007, 17, 127-136.
25. Sałagacka A, Bartczak M, Żebrowska M, Jażdżyk M, Balcerczak M, Janiuk R, Mirowski M et al.: C3435T polymorphism of the ABCB1 gene: impact on genetic susceptibility to peptic ulcers. Pharmacol Rep, 2011, 63, 992-998.
26. Schneider E, Cowan KH: Multiple drug resistance in cancer therapy. Med J Aust, 1994, 160, 371-373.
27. Taheri M, Mahjoubi F, Omranipour R: Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients. Genet Mol Res, 2010, 9, 34-40.
28. Tatari F, Salek R, Mosaffa F, Khedri A, Behravan J: Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population. DNA Cell Biol, 2009, 28, 259-263.
29. Turgut S, Yaren A, Kursunluoglu R, Turgut G: MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res, 2007, 38, 539-544. (Pubitemid 46873813)
30. Wang J, Wang B, Bi J: Significant association between ABCB1 gene C3435T polymorphism and breast cancer risk. Breast Cancer Res Treat, 2010, 126, 815-817.
31. Zebrowska M, Jazdzyk M, Salagacka A, Balcerczak M, Janiuk R, Mirowski M, Balcerczak E: Investigation of ABCB1 1236 and 2677 SNPs in patients with peptic ulcer. Scand J Gastroenterol, 2012, 47, 22-27
32. Zubor P, Lasabova Z, Hatok J, Stanclova A, Danko J: A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women. Oncol Rep, 2007, 18, 211-217.